TY - JOUR
T1 - Primary sclerosing cholangitis is associated with abnormalities in CFTR
AU - Werlin, Steven
AU - Scotet, Virginie
AU - Uguen, Kevin
AU - Audrezet, Marie Pierre
AU - Cohen, Michael
AU - Yaakov, Yasmin
AU - Safadi, Rifaat
AU - Ilan, Yaron
AU - Konikoff, Fred
AU - Galun, Eitan
AU - Mizrahi, Meir
AU - Slae, Mordechai
AU - Sayag, Shirley
AU - Cohen-Cymberknoh, Malena
AU - Wilschanski, Michael
AU - Ferec, Claude
N1 - Publisher Copyright:
© 2018
PY - 2018/9
Y1 - 2018/9
N2 - Background: The etiology of primary sclerosing cholangitis (PSC) is unknown. PSC and Cystic Fibrosis related liver disease have common features: chronic inflammation, biliary damage and similar cholangiographic findings. It is unknown whether or not PSC is related to cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction. We hypothesize that a sub-group of PSC patients may be a “single-organ” presentation of CF. Methods: Patients with PSC underwent nasal potential difference (NPD) measurement, sweat chloride measurement and complete CFTR sequencing by new generation sequencing. Results: 6/32 patients aged 46 ± 13 yrs. had CFTR causing mutations on one allele and 19 had CFTR polymorphisms; 6/23 tested had abnormal and 21 had intermediate sweat tests; 4/32 patients had abnormal NPD. One patient had chronic pancreatitis and was infertile. Conclusions: 19% of PSC patients had features of CFTR related disorder, 19% carry CFTR mutations and 50% had CFTR polymorphisms. In some patients, PSC may be a single organ presentation of CF or a CFTR-related disorder.
AB - Background: The etiology of primary sclerosing cholangitis (PSC) is unknown. PSC and Cystic Fibrosis related liver disease have common features: chronic inflammation, biliary damage and similar cholangiographic findings. It is unknown whether or not PSC is related to cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction. We hypothesize that a sub-group of PSC patients may be a “single-organ” presentation of CF. Methods: Patients with PSC underwent nasal potential difference (NPD) measurement, sweat chloride measurement and complete CFTR sequencing by new generation sequencing. Results: 6/32 patients aged 46 ± 13 yrs. had CFTR causing mutations on one allele and 19 had CFTR polymorphisms; 6/23 tested had abnormal and 21 had intermediate sweat tests; 4/32 patients had abnormal NPD. One patient had chronic pancreatitis and was infertile. Conclusions: 19% of PSC patients had features of CFTR related disorder, 19% carry CFTR mutations and 50% had CFTR polymorphisms. In some patients, PSC may be a single organ presentation of CF or a CFTR-related disorder.
KW - CFTR-related disorder
KW - Nasal potential difference
KW - New generation sequencing
KW - Primary sclerosing cholangitis
UR - http://www.scopus.com/inward/record.url?scp=85047435465&partnerID=8YFLogxK
U2 - 10.1016/j.jcf.2018.04.005
DO - 10.1016/j.jcf.2018.04.005
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 29807875
AN - SCOPUS:85047435465
SN - 1569-1993
VL - 17
SP - 666
EP - 671
JO - Journal of Cystic Fibrosis
JF - Journal of Cystic Fibrosis
IS - 5
ER -